Skip to main content
. 2020 Mar 31;24(1):21–28. doi: 10.5213/inj.1938220.110

Fig. 1.

Fig. 1.

Changes in blood glucose during the experimental period in OLETF-DA, OLETF-VO, OLETF-CO, and LETO group. LETO, Long-Evans Tokushima Otsuka; OLETF-CO, control group given water; OLETF-DA, group treated with dapagliflozin at 1.0 mg/kg/day; OLETF-VO, group treated with voglibose at 0.6 mg/kg/day. *P<0.05, OLETF-CO vs. other groups; P<0.05, OLETF-DA or OLETF-VO vs. LETO. Values are expressed as the mean±standard error.